SIMPONI ARIA® is indicated for the treatment of adults with moderately to severely active RA, in combination with methotrexate (MTX).

A fully human anti-TNF infusion given over 30 minutes

“Time” refers to a 30-minute infusion that is delivered once every 8 weeks, after starter doses at Weeks 0 and 4.1
SIMPONI ARIA® 2 mg/kg is administered as a 30-minute intravenous (IV) infusion once every 8 weeks, after starter doses at Weeks 0 and 4.1

Dosing and Administration

Helpful information for your practice

Demonstrated Efficacy

Results from a Phase 3 clinical trial

Access and Affordability

Check first-line biologic access in your state